By proceeding, you agree to our Terms of Use and Privacy Policy.
Michael joined Lhasa in 2015 working on the Mirabilis project, aiding the research and curation of knowledge relevant to understanding the potential for purging of mutagenic impurities from drug substance syntheses.
Talks About #chemistry #drugs #nmr
Preferred Locations #Europe
The formation of nitrosamines as well as other mutagenic impurities in drug substances and drug products maycompromise their safety, quality, and clinical outcomes.
The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market.
